The Marqués de Valdecilla Research Institute (IDIVAL) has launched a new technological support platform, the Metabolomics Unit, an innovative technological service designed to strengthen biomedical research through the advanced analysis of metabolites. With this initiative, IDIVAL reaffirms its commitment to scientific excellence through the application of cutting-edge tools in the field of health.
Thanks to the funding obtained through the State Sub-programme for Infrastructures and Scientific-Technical Equipment of the Strategic Action in Health 2021-2023 of the Carlos III Health Institute (Expte Nº: IFEQ22/00114), the Metabolomics Unit has two advanced chromatography equipment:
These infrastructures will allow researchers to analyse metabolic profiles with high precision, facilitating advanced studies in biomedicine, pharmacology and nutrition. In addition, the unit offers a wide range of specialised services that will contribute to the development of cutting-edge scientific projects.
This new platform is located in Tower B, floor -1 of the Marqués de Valdecilla Hospital and is coordinated by Dr. Armando Guerra and Dr. Bernardo Lavín, Clinical Analysis Service physicians, both with a solid background in the field of metabolomics and biomarker analysis.
Researchers interested in using the services of the Metabolomics Unit can obtain more information and make requests through the IDIVAL website or by contacting the team in charge directly.
With this new technological venture, IDIVAL consolidates its position as a benchmark in biomedical research, offering cutting-edge tools for the advancement of knowledge and the improvement of the health of the population.
For more information, visit: https://www.idival.org/servicios-tecnologicos/unidad-de-metabolomica/
